http://www.fpnotebook.com/
Inactivated Polio VaccineAka: Polio Vaccine, OPV, IPV, EIPV
- Indications
- Primary Immunization series
- Travel to endemic area
- Asia
- Africa
- Pathophysiology
- Reasoning in switch from OPV to EIPV
- Rare risk of poliomyelitis
- See Oral polio vaccine complications below
- All EIPV would result in no cases of polio
- But decreased mucosal (GI, mucus membrane) Immunity
- Chance for exposure from cases from Endemic areas
- China
- India
- Reasoning in switch from OPV to EIPV
- Contraindications to OPV
- Immunodeficiency disorders
- Household contacts of immunodeficient person
- Pregnancy
- Hypersensitivity to vaccine
- Anaphylactic reaction to neomycin or Streptomycin
- Dose
- Adults: EIPV 0.5 ml SC
- Schedule (New recommended schedule)
- Recent modification recommends EIPV for all 4 doses
- Dose 1: Age 2 months
- Dose 2: Age 4 months
- Dose 3: Age 6 to 18 months
- Dose 4: Age 4 to 6 years
- Recent modification recommends EIPV for all 4 doses
- Precaution
- EIPV is Safe in HIV and Pregnancy
- Avoid OPV in HIV and Pregnancy
- Complications: Oral polio vaccine (OPV)
- Cases per year Poliomyelitis associated with OPV: 8
- One case per 2 million doses
- EIPV results in no cases of poliomyelitis
- Cases per year Poliomyelitis associated with OPV: 8
- References
Poliovirus Vaccine, Oral (C0032375) | |
|---|---|
| Definition (MSH) | A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed) |
| Definition (HL7V3.0) | poliovirus vaccine, live, oral |
| Concepts | Pharmacologic Substance (T121) , Immunologic Factor (T129) |
| MSH | D011055 |
| English | OPV, Oral Poliovirus Vaccine, Sabin Vaccine, TOPV |
| Spanish | vacuna de Sabin |
| Parent Concepts | Vaccines administered (code = CVX)(parenteral, unless oral is noted) (C1547693), VaccineType (C1554000), Poliovirus Vaccines (C0032374) |
| Sources | HL7V2.5, HL7V3.0, LCH, MSH, SCTSPA, SNOMEDCT Derived from the NIH UMLS (Unified Medical Language System) |
Poliovirus Vaccine, Inactivated (C0718003) | |
|---|---|
| Definition (MSH) | A suspension of formalin-inactivated poliovirus grown in monkey kidney cell tissue culture and used to prevent POLIOMYELITIS. |
| Definition (HL7V3.0) | poliovirus vaccine, inactivated |
| Concepts | Pharmacologic Substance (T121) , Immunologic Factor (T129) |
| MSH | D011054 |
| English | Inactivated poliomyelitis vaccine, Inactivated poliovirus vaccine, IPV, POLIOVIRUS VACCINE INACTIVATED, POLIOVIRUS VACCINE INACTIVATED PREPARATION |
| Spanish | vacuna antipoliomielitica a virus inactivados, vacuna antipoliomielitica de virus inactivados |
| Parent Concepts | Vaccines administered (code = CVX)(parenteral, unless oral is noted) (C1547693), VaccineType (C1554000), Poliovirus Vaccines (C0032374), Vaccines, Inactivated (C0042212), Drug allergen (C1320237), Vaccines (C0042210) |
| Sources | HL7V2.5, HL7V3.0, MSH, MTH, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
